IDEXX Laboratories, Inc.

IDEXX Laboratories, Inc.

IDEXX Laboratories, Inc. (IDXX) is a Medical diagnostics research company in the Healthcare sector, listed on Nasdaq. This page provides the complete earnings calendar, dividend schedule, and financial data for IDEXX Laboratories, Inc. in 2026. The next earnings report is expected on November 3, 2026.

Earnings calendar

Next earnings date

03 Nov 2026

In 75 days

EPS estimate

3.77

Revenue estimate

1.2B

Past earnings

04 Aug 2026
EPS actual
4.27 (+8.3%)
estimate 3.94
Revenue actual
1.2B (+1.4%)
estimate 1.2B
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
05 May 2026
EPS actual
3.47 (+1.8%)
estimate 3.41
Revenue actual
1.1B (+2.0%)
estimate 1.1B
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
02 Feb 2026
EPS actual
3.08 (+5.0%)
estimate 2.93
Revenue actual
1.1B (+1.7%)
estimate 1.1B
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
03 Nov 2025
EPS actual
3.40 (+8.3%)
estimate 3.14
Revenue actual
1.1B (+3.0%)
estimate 1.1B
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Beat Miss usd

Latest earnings analysis

IDEXX Laboratories, Inc. beat consensus estimates in its latest earnings report, with EPS of $4.27 coming in 8.3% above expectations and revenue of $1.22 billion exceeding estimates by 1.4%. Both EPS and revenue also came in ahead of expectations in the previous report.

Dividend calendar

No dividend history available.

EPS (Earnings Per Share)

Revenue

Company profile

IDEXX Laboratories, Inc. is a global enterprise dedicated to creating, producing, and distributing a broad spectrum of products and services. Its primary focus lies in serving the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company delivers crucial solutions across several key areas. For companion animals, IDEXX offers comprehensive veterinary diagnostic tools, including in-clinic point-of-care instruments, consumables, and rapid assay test kits. They also provide expert veterinary reference laboratory diagnostics, consulting services, and advanced practice management and diagnostic imaging systems. Beyond pets, their portfolio extends to health monitoring and diagnostic products vital for livestock, poultry, and dairy farming. In the water quality segment, IDEXX manufactures tests designed to detect various microbiological contaminants, ensuring safety and compliance, with notable examples like the Colilert, Enterolert, and Legiolert tests. IDEXX also serves the biomedical research community with health monitoring and laboratory animal diagnostic instruments and services. Furthermore, they contribute to human point-of-care medical diagnostics by providing specialized electrolytes and blood gas analyzers, alongside SARS-CoV-2 RT-PCR solutions. Their extensive product lineup features various in-clinic chemistry, blood, and urine analyzers (such as the SediVue Dx), hematology systems, and rapid diagnostic assays like SNAP test kits. Complementing these offerings, the company provides essential veterinary software solutions for both independent and corporate veterinary practices. Sales and distribution are managed through their dedicated marketing, customer service, sales, and technical support teams, supplemented by a network of independent distributors and other resellers. Established in 1983, IDEXX Laboratories, Inc. maintains its headquarters in Westbrook, Maine.

Sector
Healthcare
Industry
Medical diagnostics research
Country
United States
Exchange
Nasdaq
Indices
Nasdaq 100, S&P 500
CEO
Michael Erickson
Employees
11,000
IPO date
19 Jan 2018
ISIN
US45168D1046
Website
idexx.com

Frequently asked questions

When does IDEXX Laboratories, Inc. (IDXX) next report earnings?

IDEXX Laboratories, Inc. (IDXX) is scheduled to report earnings on November 3, 2026.

What was IDEXX Laboratories, Inc.'s most recent earnings date?

IDEXX Laboratories, Inc. (IDXX) last reported earnings on August 4, 2026.

Where is IDEXX Laboratories, Inc. stock listed?

IDEXX Laboratories, Inc. (IDXX) is listed on Nasdaq.